Scientific Industries (SCND) chairman adds 9,000 shares in open-market buy

Rhea-AI Filing Summary

SCIENTIFIC INDUSTRIES INC Chairman John A. Moore bought additional shares of the company’s stock. On this Form 4, he reports an open-market purchase of 9,000 shares of Common Stock at a price of $0.58 per share on March 23, 2026.

Following this transaction, Moore directly owns 926,871 shares of Scientific Industries common stock. This filing reflects a net increase in his holdings, as there were no reported sales, option exercises, or derivative transactions in this disclosure.

Insider Trade Summary

Net Buyer: 9,000 shares ($5,220)

Net Buy 1 txn

Insider MOORE JOHN A

Role Chairman

Bought 9,000 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	9,000	$0.58	$5K

Holdings After Transaction: Common Stock — 926,871 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORE JOHN A

(Last) (First) (Middle)

403 MARSH LANE

(Street)

WILMINGTON DELAWARE 19807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ SCND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/23/2026	03/23/2026	P		9,000	A	$0.58	926,871	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	John Moore	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SCIENTIFIC INDUSTRIES INC (SCND) report on this Form 4?

The Form 4 reports that Chairman John A. Moore made an open-market purchase of 9,000 shares of Common Stock at $0.58 per share on March 23, 2026. This transaction increased his direct ownership position in the company.

How many SCIENTIFIC INDUSTRIES INC (SCND) shares does John A. Moore own after this trade?

After the reported transaction, John A. Moore directly owns 926,871 shares of Scientific Industries common stock. This figure reflects his total direct holdings immediately following the 9,000-share open-market purchase disclosed in the Form 4 filing.

Was the SCIENTIFIC INDUSTRIES INC (SCND) insider trade a purchase or a sale?

The insider trade was a purchase. The Form 4 lists transaction code P, described as an open-market or private purchase, with 9,000 shares of Common Stock bought at $0.58 per share and no shares reported as sold in this filing.

What role does John A. Moore hold at SCIENTIFIC INDUSTRIES INC (SCND)?

John A. Moore is identified as both a director and an officer of Scientific Industries Inc, serving in the role of Chairman. His insider status requires disclosure of equity transactions like the 9,000-share open-market purchase reported here.

Does the SCIENTIFIC INDUSTRIES INC (SCND) Form 4 show any derivative or option activity?

No, this Form 4 only reports a non-derivative transaction in Common Stock. The derivativeSummary section is empty, indicating no options, warrants, or other derivative securities were exercised, converted, granted, or otherwise transacted in this particular filing.